Home > Healthcare > Medical Devices > Therapeutic Devices > Brachytherapy Devices Market

Brachytherapy Devices Market Trends

Report ID: GMI6561
Published Date: Aug 2023
Report Format: PDF

Download Free Sample

Brachytherapy Devices Market Trends

Rapid technological progress has significantly enhanced the precision and effectiveness of brachytherapy. For instance, Isoray Medical, Inc. obtained clearance from the U.S. Food and Drug Administration (FDA) to utilize C4 Imaging's Sirius markers, which produce positive MRI (Magnetic Resonance Imaging) signals, in conjunction with Isoray's Cesium-131 brachytherapy seeds. Thus, advanced imaging techniques such as Magnetic Resonance Imaging (MRI), Computerized Tomography (CT) scans, and Positron Emission Tomography (PET) scans enable medical professionals to accurately visualize tumor sites, aiding in treatment planning. Furthermore, computerized treatment planning systems allow intricate customization of radiation doses and angles to optimize therapy outcomes. Therefore, such advancements enhance the procedural success rate as well as reduce potential side effects for patients thereby, stimulating the market progress.

Additionally, growing government initiatives, Funding for cancer research & development, developing healthcare infrastructure, and patient support programs will spur the adoption of advanced cancer treatment methods, including brachytherapy, and propelling market revenue.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

The global brachytherapy devices industry was valued at USD 716 Million in 2022 and is estimated to account for USD 1.3 billion by 2032.

The low dose rate (LDR) segment size was 78.5% in 2022 and will witness a rapid growth through 2032 attributable to its controlled radiation release and compatibility with personalized medicine.

U.S. brachytherapy devices market accounted for USD 270.5 million in 2022 and is predicted to witness substantial growth through 2032, owing to the increasing geriatric population base along with the rising incidence of cancer in the country.

Merit Medical Systems, Inc., Elekta AB, Isoray Medical, Inc., Becton Dickinson & Company, Eckert & Ziegler BEBIG, CIVCO Medical Solutions, iCAD, Inc., Theragenics Corporation, Siemens AG, IsoAid, Carl Zeiss AG and Argon Medical Devices, Inc. among others.